Letter: The risk-benefit balance of CRISPR-Cas screening systems in gene editing and targeted cancer therapy
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Journal of Translational Medicine |
| Online Access: | https://doi.org/10.1186/s12967-024-05834-z |